The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Deoxyribonucleic Acid (DNA) Manufacturing Market Evolve From 2026 To 2030?
The deoxyribonucleic acid (dna) manufacturing market has experienced substantial expansion recently. This market is projected to expand from $5.58 billion in 2025 to $6.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.7%. Historically, this growth has stemmed from several factors, including challenges in obtaining high-quality plasmid and synthetic dna, a dependence on conventional chemical dna synthesis techniques, escalating research and development efforts in cell and gene therapies, increasing academic and industrial research projects, and a surging need for oligonucleotide-based medications.
The deoxyribonucleic acid (dna) manufacturing market size is anticipated to experience substantial growth in the coming years. It is forecast to expand to $11.95 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This projected expansion during the forecast period is primarily driven by advancements in enzymatic and chemical DNA synthesis technologies, the broadening of gene therapy and vaccine pipelines, increasing uptake of GMP-grade DNA production, a rising demand for long and complex DNA constructs, and the integration of automated DNA manufacturing platforms and digital workflows. Significant trends for this period include an escalating demand for GMP-grade DNA in therapeutic applications, an increase in plasmid and synthetic DNA production for vaccines, the growing adoption of gene synthesis and codon optimization services, the expansion of oligonucleotide synthesis for PCR, siRNA, and antisense applications, and the embedding of DNA manufacturing within cell and gene therapy development pipelines.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27272&type=smp
What Drivers Are Influencing The Deoxyribonucleic Acid (DNA) Manufacturing Market?
The deoxyribonucleic acid (DNA) manufacturing market is anticipated to expand, driven by the escalating demand for gene therapies. Gene therapies involve methods for altering or substituting defective genes to prevent or treat illnesses, while personalized medicine focuses on customizing medical care based on an individual’s genetic makeup, biology, and lifestyle attributes. This growing need for gene therapies stems from the increasing occurrence of genetic conditions, including cystic fibrosis, sickle cell anemia, and specific forms of inherited blindness. Deoxyribonucleic acid (DNA) manufacturing plays a crucial role in gene therapies, supplying the specialized, high-quality DNA sequences required for creating and delivering therapeutic genes capable of rectifying or substituting defective genetic material in patients. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization, in fourth quarter of 2024, the number of pre-registration gene therapy programs experienced its largest increase in over a year, rising 83% compared to third quarter of 2024. Consequently, the expanding demand for gene therapies is fueling the expansion of the deoxyribonucleic acid (DNA) manufacturing market.
Which Segment Areas Are Covered In The Deoxyribonucleic Acid (DNA) Manufacturing Market Analysis?
The deoxyribonucleic acid (dna) manufacturing market covered in this report is segmented –
1) By Type: Plasmid Deoxyribonucleic Acid (DNA), Synthetic Deoxyribonucleic Acid (DNA), Gene Synthesis, Oligonucleotide Synthesis
2) By Grade: Good Manufacturing Practices (GMP) Grade, Research And Development Grade
3) By Application: Cell And Gene Therapy, Vaccines, Oligonucleotide-Based Drugs, Other Applications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations
Subsegments:
1) By Plasmid Deoxyribonucleic Acid (DNA): GMP-Grade Plasmid DNA, Non-GMP-Grade Plasmid DNA, High Copy Number Plasmids, Low Copy Number Plasmids, Bacterial Fermentation-Based Plasmid Production, Transfection-Grade Plasmid DNA
2) By Synthetic Deoxyribonucleic Acid (DNA): Enzymatic DNA Synthesis, Chemical DNA Synthesis, Long DNA Fragments, Short DNA Fragments, Single-Stranded Synthetic DNA, Double-Stranded Synthetic DNA
3) By Gene Synthesis: Custom Gene Synthesis, Standard Gene Synthesis, Complex Gene Constructs, Codon Optimization Services, Gene Library Synthesis
4) By Oligonucleotide Synthesis: DNA Oligonucleotides, Modified Oligonucleotides, Long Oligonucleotides, PCR Primers, SiRNA And Antisense Oligos, Adapter And Linker Oligos
What Key Developments And Trends Are Impacting The Deoxyribonucleic Acid (DNA) Manufacturing Market?
Companies prominent in the DNA manufacturing market are concentrating on creating innovative methods, such as GMP-grade plasmid DNA production, to improve the quality, safety, and scalability of gene and cell therapy applications. GMP-grade plasmid DNA production refers to the manufacturing of plasmid DNA under Good Manufacturing Practice (GMP) conditions, which are regulatory guidelines designed to assure the quality, safety, and consistency of biopharmaceutical products. For instance, in April 2025, ProBio Genomics Inc., a US-based contract development and manufacturing organization (CDMO), launched GMP Plasmid DNA Manufacturing Services in Hopewell, complete with in-house analytical testing, method development, and project management. This service offers distinct features, including in-house process development, analytical testing, method development, and project management, thereby removing the necessity for multiple suppliers and accelerating development timelines. The service guarantees a high-quality output with =85% supercoiled plasmid DNA content while diminishing contamination risks. ProBio further provides GMP-like plasmids with a four-week delivery timeline and full GMP-grade plasmids within three months.
Which Global Companies Are Actively Competing In The Deoxyribonucleic Acid (DNA) Manufacturing Market?
Major companies operating in the deoxyribonucleic acid (dna) manufacturing market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Kaneka Corporation, Catalent Inc., Charles River Laboratories International Inc., WuXi Biologics Inc., AGC Biologics Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio USA Inc., Twist Bioscience Corp., Ajinomoto Bio-Pharma Services, OriGene Technologies Inc., DNA Script SAS, Eurofins Genomics LLC, Touchlight Genetics Ltd., Elegen Inc., VGXI Inc., PlasmidFactory GmbH & Co. KG.
Read the full deoxyribonucleic acid (dna) manufacturing market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Deoxyribonucleic Acid (DNA) Manufacturing Market?
North America was the largest region in the deoxyribonucleic acid (DNA) manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the deoxyribonucleic acid (dna) manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Deoxyribonucleic Acid (DNA) Manufacturing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27272&type=smp
Browse Through More Reports Similar to the Global Deoxyribonucleic Acid (DNA) Manufacturing Market 2026, By The Business Research Company
Electronic Equipment Repair Service Market Report 2026
Maintenance Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/maintenance-services-global-market-report
Industrial Maintenance Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model